BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 17824899)

  • 1. Increased plasma levels of cytokines after seizures in localization-related epilepsy.
    Lehtimäki KA; Keränen T; Palmio J; Mäkinen R; Hurme M; Honkaniemi J; Peltola J
    Acta Neurol Scand; 2007 Oct; 116(4):226-30. PubMed ID: 17824899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-6, interleukin-1 receptor antagonist and interleukin-1beta production in patients with focal epilepsy: A video-EEG study.
    Alapirtti T; Rinta S; Hulkkonen J; Mäkinen R; Keränen T; Peltola J
    J Neurol Sci; 2009 May; 280(1-2):94-7. PubMed ID: 19272615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levels of IL-1beta and IL-1ra in cerebrospinal fluid of human patients after single and prolonged seizures.
    Lehtimäki KA; Keränen T; Palmio J; Peltola J
    Neuroimmunomodulation; 2010; 17(1):19-22. PubMed ID: 19816053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential early posttransplant cytokine responses in living and cadaver donor renal allografts.
    Sadeghi M; Daniel V; Weimer R; Wiesel M; Hergesell O; Opelz G
    Transplantation; 2003 Apr; 75(8):1351-5. PubMed ID: 12717229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-6, interleukin-1 beta and interleukin-1 receptor antagonist levels in epileptic seizures.
    Uludag IF; Bilgin S; Zorlu Y; Tuna G; Kirkali G
    Seizure; 2013 Jul; 22(6):457-61. PubMed ID: 23566695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Etiology and site of temporal lobe epilepsy influence postictal cytokine release.
    Bauer S; Cepok S; Todorova-Rudolph A; Nowak M; Köller M; Lorenz R; Oertel WH; Rosenow F; Hemmer B; Hamer HM
    Epilepsy Res; 2009 Sep; 86(1):82-8. PubMed ID: 19520550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of IL-6 system in cerebrospinal fluid and serum compartments by seizures: the effect of seizure type and duration.
    Lehtimäki KA; Keränen T; Huhtala H; Hurme M; Ollikainen J; Honkaniemi J; Palmio J; Peltola J
    J Neuroimmunol; 2004 Jul; 152(1-2):121-5. PubMed ID: 15223244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can the interleukin-1 receptor antagonist (IL-1ra) be a marker of anti-inflammatory response to enteral immunonutrition in malnourished patients after pancreaticoduodenectomy?
    Slotwinski R; Olszewski WL; Slotkowski M; Lech G; Zaleska M; Slotwinska SM; Krasnodebski WI
    JOP; 2007 Nov; 8(6):759-69. PubMed ID: 17993728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Depressive symptomatology is associated with decreased interleukin-1 beta and increased interleukin-1 receptor antagonist levels in males.
    Ovaskainen Y; Koponen H; Jokelainen J; Keinänen-Kiukaanniemi S; Kumpusalo E; Vanhala M
    Psychiatry Res; 2009 May; 167(1-2):73-9. PubMed ID: 19346005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic and local cytokine kinetics after total hip replacement surgery.
    Bastian D; Tamburstuen MV; Lyngstadaas SP; Reikerås O
    Eur Surg Res; 2008; 41(4):334-40. PubMed ID: 18815447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphisms of the gene encoding the inflammatory cytokine interleukin-6 determine the magnitude of the increase in soluble interleukin-6 receptor levels in Alzheimer's disease. Results of a pilot study.
    Bagli M; Papassotiropoulos A; Hampel H; Becker K; Jessen F; Bürger K; Ptok U; Rao ML; Möller HJ; Maier W; Heun R
    Eur Arch Psychiatry Clin Neurosci; 2003 Feb; 253(1):44-8. PubMed ID: 12664314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble interleukin 6 receptor: A novel marker of moderate to severe sleep-related breathing disorder.
    Mehra R; Storfer-Isser A; Kirchner HL; Johnson N; Jenny N; Tracy RP; Redline S
    Arch Intern Med; 2006 Sep; 166(16):1725-31. PubMed ID: 16983050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-6 signalling in juvenile idiopathic arthritis is limited by proteolytically cleaved soluble interleukin-6 receptor.
    Peake NJ; Khawaja K; Myers A; Nowell MA; Jones SA; Rowan AD; Cawston TE; Foster HE
    Rheumatology (Oxford); 2006 Dec; 45(12):1485-9. PubMed ID: 16690760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-1β, IL-6 and IL1Ra levels in temporal lobe epilepsy.
    Uludag IF; Duksal T; Tiftikcioglu BI; Zorlu Y; Ozkaya F; Kirkali G
    Seizure; 2015 Mar; 26():22-5. PubMed ID: 25799897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulated T cells generate microparticles, which mimic cellular contact activation of human monocytes: differential regulation of pro- and anti-inflammatory cytokine production by high-density lipoproteins.
    Scanu A; Molnarfi N; Brandt KJ; Gruaz L; Dayer JM; Burger D
    J Leukoc Biol; 2008 Apr; 83(4):921-7. PubMed ID: 18223103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increase in plasma proinflammatory cytokines after electroconvulsive therapy in patients with depressive disorder.
    Lehtimäki K; Keränen T; Huuhka M; Palmio J; Hurme M; Leinonen E; Peltola J
    J ECT; 2008 Mar; 24(1):88-91. PubMed ID: 18379341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating interleukin-6 family cytokines and their receptors in patients with congestive heart failure.
    Hirota H; Izumi M; Hamaguchi T; Sugiyama S; Murakami E; Kunisada K; Fujio Y; Oshima Y; Nakaoka Y; Yamauchi-Takihara K
    Heart Vessels; 2004 Sep; 19(5):237-41. PubMed ID: 15372299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immune factors or depression? Fatigue correlates in Parkinson's disease].
    Katsarou Z; Bostantjopoulou S; Hatzizisi O; Giza E; Soler-Cardona A; Kyriazis G
    Rev Neurol; 2007 Dec 16-31; 45(12):725-8. PubMed ID: 18075986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perfusion with lipopolysaccharide differently affects the secretion of interleukin-1 beta and interleukin-1 receptor antagonist by term and preterm human placentae.
    Holcberg G; Amash A; Sapir O; Sheiner E; Levy S; Myatt L; Huleihel M
    Placenta; 2008 Jul; 29(7):593-601. PubMed ID: 18471873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired counter-regulation of interleukin-1 by the soluble IL-1 receptor type II in patients with chronic liver disease.
    Ludwiczek O; Vannier E; Moschen A; Salazar-Montes A; Borggraefe I; Gabay C; Enrich B; Kaser A; Siegmund B; Dinarello C; Tilg H
    Scand J Gastroenterol; 2008; 43(11):1360-5. PubMed ID: 18609176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.